Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 22. April 2024
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8043  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 160843  
   
Toward a new personalized psycho-social approach for the support of prostate cancer and their caregivers dyads: a pilot study.
Front Med (Lausanne)
Cincidda C, Pizzoli SFM, Oliveri S, Guiddi P, Pravettoni G.
PMID: 38646557 [PubMed]


Association between monocyte-to-lymphocyte ratio and prostate cancer in the U.S. population: a population-based study.
Front Cell Dev Biol
Wang L, Li X, Liu M, Zhou H, Shao J.
PMID: 38645410 [PubMed]


Translation and validation of a lifestyle questionnaire related to prostate cancer.
Prostate
Karegar-Niavol R, Ghaffari F, Saravi A, Fotokian Z, Kheirkhah F.
PMID: 38644626 [PubMed - as supplied by publisher]


Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis.
Eur Urol Oncol
Cerrato C, Crocerossa F, Marchioni M, Giannarini G, Gupta S, Albiges L, Brouwer O, Albersen M, Fankhauser C, Grimm MO, Gandaglia G, Roupret M, Mir MC, ESOU Board.
PMID: 38644155 [PubMed - as supplied by publisher]


Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study.
Eur Urol
Saad F, Hussain MHA, Tombal B, Fizazi K, Sternberg CN, Crawford ED, Nordquist LT, Bögemann M, Tutrone R, Shore ND, Belkoff L, Fralich T, Jhaveri J, Srinivasan S, Li R, Verholen F, Kuss I, Smith MR.
PMID: 38644146 [PubMed - as supplied by publisher]


Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [(177)Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.08.026.
Eur Urol
Hindié E, Champion C, Morgat C.
PMID: 38644143 [PubMed - as supplied by publisher]


Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial. Eur Urol 2024;85:105-11.
Eur Urol
Cardona Ortegón JD, Campaña Perilla LA, Olarte Bermúdez LM.
PMID: 38644137 [PubMed - as supplied by publisher]


Efficacy and safety of metronomic cyclophosphamide combined with abiraterone and dexamethasone in heavily pretreated metastatic castration resistant prostate cancer:A retrospective, real-world study.
Asian J Surg
Zhang L, Zhou L, Shi Y, An X.
PMID: 38644125 [PubMed - as supplied by publisher]


Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years.
PET Clin
Dalm S, Duan H, Iagaru A.
PMID: 38644111 [PubMed - as supplied by publisher]


Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer.
Urol Oncol
Cei F, Larcher A, Rosiello G, Basile G, Musso G, Re C, Fallara G, Belladelli F, Brembilla G, Guazzarotti G, De Cobelli F, Marandino L, Necchi A, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U.
PMID: 38644109 [PubMed - as supplied by publisher]


Cancer on motors: How kinesins drive prostate cancer progression?
Biochem Pharmacol
Wang JM, Zhang FH, Liu ZX, Tang YJ, Li JF, Xie LP.
PMID: 38643904 [PubMed - as supplied by publisher]


Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer.
Clin Genitourin Cancer
Tashiro K, Kimura S, Tsuzuki S, Urabe F, Fukuokaya W, Mori K, Aikawa K, Murakami M, Sasaki H, Miki K, Miki J, Shimomura T, Yamada H, Hata K, Nishikawa H, Abe H, Watanabe K, Kimura T.
PMID: 38643665 [PubMed - as supplied by publisher]


AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer.
Aging (Albany NY)
Deng Y, Zhang C, Yu H, Chen G, Peng X, Li Y, Feng Z, Shi W, Bai X, Gou X, Liu N.
PMID: 38643469 [PubMed - as supplied by publisher]


Single-port robot-assisted radical prostatectomy.
World J Urol
Soputro NA, Kaouk J.
PMID: 38643347 [PubMed - indexed for MEDLINE]


Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence.
Prostate Cancer Prostatic Dis
Dorff T, Kashid SR, Murthy V, Lombardo R, De Nunzio C.
PMID: 38643307 [PubMed - as supplied by publisher]


Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.
Eur J Med Res
Wan L, Fan Y, Wu T, Liu Y, Zhang R, Chen S, Zhao C, Xue Y.
PMID: 38643190 [PubMed - indexed for MEDLINE]


The effects of different positions on lower extremity hemodynamics during robot-assisted laparoscopic radical prostatectomy for prostate cancer.
BMC Urol
Wang Z, Wang X, Yu X.
PMID: 38643097 [PubMed - indexed for MEDLINE]


Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial.
ESMO Open
Powles T, Burotto M, Escudier B, Apolo AB, Bourlon MT, Shah AY, Suárez C, Porta C, Barrios CH, Richardet M, Gurney H, Kessler ER, Tomita Y, Bedke J, George S, Scheffold C, Wang P, Fedorov V, Motzer RJ, Choueiri TK.
PMID: 38642472 [PubMed - as supplied by publisher]


Urethral carcinoma after skin substitution urethral reconstruction.
Can J Urol
Wu Z, Chen M, Mori R.
PMID: 38642465 [PubMed - indexed for MEDLINE]


Hand, foot, and mouth disease presenting with a testicular mass in an adult.
Can J Urol
Azari S, Wolfman D, Smith A.
PMID: 38642464 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 160843    Seite 1 von 8043  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1